Your session is about to expire
← Back to Search
Artificial Tears
FreshKote for Dry Eye Syndrome
Phase 4
Waitlist Available
Led By Mitch Jackson, MD
Research Sponsored by Innovative Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three months
Awards & highlights
Study Summary
The purpose of this study is to compare the efficacy of FreshKote and Systane for the reduction of dry eye signs and symptoms.
Eligible Conditions
- Dry Eye Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ three months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Best Corrected Visual Acuity
TBUT
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: FreshKoteActive Control1 Intervention
Group II: SystanePlacebo Group1 Intervention
Find a Location
Who is running the clinical trial?
Innovative MedicalLead Sponsor
51 Previous Clinical Trials
2,588 Total Patients Enrolled
Mitch Jackson, MDPrincipal InvestigatorJackson Eye, S.C
1 Previous Clinical Trials
60 Total Patients Enrolled
Jay Pepose, MDPrincipal InvestigatorPepose Vision Institute
1 Previous Clinical Trials
200 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger